SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-May-24 7:19 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-May-24 | Private Purchase | 36,300 | $5.57 | $202,191.00 | 16% 230.44K to 266.74K | |
20-Dec-23 4:35 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 2,482 | $6.05 | $15,016.10 | (1%) 229.93K to 227.44K | |
18-Dec-23 4:37 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 34,000 | -- | -- | 17% 201.4K to 235.4K | |
18-Dec-23 4:37 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 5,475 | $6.43 | $35,204.20 | (2%) 235.4K to 229.93K | |
21-Dec-22 4:32 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-22 | Grant | 34,000 | -- | -- | 21% 163.97K to 197.97K | |
19-Dec-22 4:55 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Dec-22 | Sale | 5,700 | $10.90 | $62,130.00 | (3%) 169.67K to 163.97K | |
16-Dec-21 4:59 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-21 | Grant | 115,000 | -- | -- | 123% 93.72K to 208.72K | |
24-Nov-21 6:35 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 23-Nov-21 | Market Purchase | 35,258 | $12.48 | $440,020.00 | 60% 58.46K to 93.72K | (< 1%) |
12-Aug-20 4:31 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 11-Aug-20 | Market Purchase | 54,000 | $4.08 | $220,320.00 | 100% 0 to 54.0K | 86% |